This company raised $100 million to bring gene therapy to the masses:
Over the past several years, breakthroughs in gene therapy have led to treatments for rare diseases that were deadly just a decade ago. Take Zolgensma—in 2019, it was the first gene therapy approved by the FDA to treat spinal muscular atrophy, a rare genetic disease that affects the mobility of infants and children. But gene therapies have historically had two drawbacks: They are only used for rare diseases, and they carry a hefty price tag .
“We think this is going to be an extraordinarily important therapeutic class that will revolutionize the treatment of many diseases,” says Jim Momtazee, managing partner at Patient Square Capital. Kriya’s main focus is its uniquely designed Adeno-associated viruses—viruses that are harmless when they enter the body, but deliver instructions to cells that then pump out genes that are missing in some people with genetic diseases. Though the company still plans to develop treatments for rare diseases, what sets it apart is its focus on more common genetic diseases, like some forms of diabetes and obesity.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Adorable video shows paraplegic dog falling asleep while relaxing in poolChewie has been viewed over five million times, after falling asleep during a swim therapy class to soothe her spine arthritis and bridging.
Read more »
PepsiCo earnings crush estimates as restaurant demand returns, company raises forecastPepsiCo on Tuesday reported that its quarterly revenue rose more than 20% as restaurant demand for its drinks returned, fueling an earnings beat.
Read more »
SuperAnnotate Raises $14.5 Million To Help Automate The Computer Vision PipelineI'm a reporter covering venture capital, startups and investors out of New York. I was previously a reporter at the Venture Capital Journal and Private Debt Investor. I graduated early from Emerson College in 2017 with a degree in journalism. Follow me on twitter at rebecca_szkutak or send me an email at rszkutakforbes.com.
Read more »
Fast-Growing Analytics Startup Amplitude, Founded By Forbes 30 Under 30 Alums, Files To Go PublicAnalytics startup Amplitude filed confidentially to go public in a direct listing today, just one month after raising $150 million in new funding at a $4 billion valuation led by Sequoia.
Read more »
Finally a win for Britney Spears in the conservatorship battle'You're allowing my dad to ruin my life,' Britney Spears says at the conservatorship hearing in which she won the right to chose her own lawyer
Read more »